Publicly traded medtech buys $40M bitcoin in nod to MicroStrategy

Semler Scientific, a publicly traded medical tech company, joined MicroStrategy by buying up millions of bitcoin

May 28, 2024 10:21 am

Semler Scientific and Adobe Stock modified by Blockworks

Semler Scientific, a medical technology company, announced that it bought 581 bitcoin for roughly $40 million.

The company also adopted bitcoin as its primary treasury reserve asset.

Semler is listed on Nasdaq under the ticker SMLR. The stock took off after the announcement, soaring over $25 at time of publication.

“Our bitcoin treasury strategy and purchase of bitcoin underscore our belief that bitcoin is a reliable store of value and a compelling investment,” said Eric Semler, Semler Scientific’s Chairman, in a press release.

Newsletter

Subscribe to The Breakdown

The company, he added, believes that bitcoin can act as an inflation hedge and safe haven against global instability.

“Given the gap in value between gold and bitcoin, we believe that bitcoin has the potential to generate outsize returns as it gains increasing acceptance as digital gold,” Semler added.

In April, Coinbase analyst David Han said that bitcoin’s rising correlation to gold could “signal its increased footing as a sensitive macro asset in the absence of crypto-specific catalysts like spot ETF approvals.”

The company will now devote excess cash to buying bitcoin, though it’ll continually monitor the “anticipated cash needs” of the company.

Semler’s strategy shifts puts it in the same playing field as MicroStrategy, though the latter has billions worth of bitcoin.

And it’s not the only company to recently make the move to prioritize bitcoin. Japanese company Metaplanet announced earlier this year that it would be making a “strategic treasury transformation” after the Japanese yen exhibited weakness.

While US-based Semler doesn’t have to deal with the same currency issues as the Japanese company, the shift shows that companies are taking a look at bitcoin.

Get the news in your inbox. Explore Blockworks newsletters:

The Breakdown: Decoding crypto and the markets. Daily.
0xResearch: Alpha in your inbox. Think like an analyst.

Tags

Newsletter

The Breakdown

Decoding crypto and the markets. Daily, with Byron Gilliam.

Upcoming Events

Digital Asset Summit 2026

Javits Center North | 445 11th Ave

Tues - Thurs, March 24 - 26, 2026

Blockworks’ Digital Asset Summit (DAS) will feature conversations between the builders, allocators, and legislators who will shape the trajectory of the digital asset ecosystem in the US and abroad.

buy tickets learn more

recent research

Research

Kinetiq Protocol: From LST Infrastructure to HIP-3 Deployer

Kinetiq has established itself as Hyperliquid's dominant liquid staking protocol, holding 82.5% of LST market share with $610M in TVL. The protocol is now expanding beyond its kHYPE staking core into higher take-rate verticals: iHYPE for institutional custody rails, Launch for HIP-3 capital formation, and Markets for builder-deployed perpetuals. We view Markets, launching Jan. 12, as the highest-potential product line given its mechanically scalable, activity-linked unit economics. Near-term revenue remains anchored by kHYPE's KIP-2 fee schedule (~$1.6M annualized), while Markets provides embedded optionality if HIP-3 economics normalize post-Growth Mode. KNTQ's setup is relatively clean: zero insider unlocks until November 2026, 6.2% buyback yield from staking revenue, and cleared airdrop overhang. Risks center on unproven Markets execution, declining kHYPE TVL despite ongoing incentives, and competition from Hyperliquid's native initiatives.

by Shaunda Devens